Abiopharma

Clinical trial NCT06421740 updates: 1. status: RECRUITING → COMPLETED 2. completion date: 2026-06-01 → 2026-05-25 3. primary completion date: 2026-06-01 → 2026-05-25 4. enrollment type: ESTIMATED → ACTUAL

Clinical trial NCT04401020: status: COMPLETED → TERMINATED.

Clinical trial NCT05814627 updates: 1. status: ACTIVE_NOT_RECRUITING → COMPLETED 2. completion date: 2026-07-01 → 2026-07-15 3. primary completion date: 2026-07-01 → 2026-07-15

Clinical trial NCT07282665 updates: 1. enrollment: 32000 → 32500 participants 2. masking: TRIPLE → QUADRUPLE

Clinical trial NCT06681896 updates: 1. completion date: 2027-01-01 → 2027-08-01 2. primary completion date: 2027-01-01 → 2027-04-01

Clinical trial NCT07287189: completion date: 2027-06-30 → 2028-02-28.

Clinical trial NCT03283605 updates: 1. status: ACTIVE_NOT_RECRUITING → COMPLETED 2. enrollment: 45 → 33 participants 3. enrollment type: ESTIMATED → ACTUAL

Clinical trial NCT04736706 updates: 1. completion date: 2026-10-29 → 2027-04-22 2. primary completion date: 2026-10-29 → 2026-02-04 3. enrollment: 1653 → 1854 participants 4. enrollment type: ESTIMATED → ACTUAL

New Form N-PX - FIRST TRUST ENHANCED EQUITY INCOME FUND <b>Filed:</b> 2026-08-14 <b>AccNo:</b> 0001445546-26-006035 <b>Size:</b> 738 KB

Clinical trial NCT05067543 updates: 1. completion date: 2036-12-01 → 2037-12-01 2. primary completion date: 2036-06-30 → 2037-06-30

New Form 13F-HR - RAYMOND JAMES FINANCIAL INC <b>Filed:</b> 2026-08-14 <b>AccNo:</b> 0000720005-26-000071 <b>Size:</b> 7 MB

Clinical trial NCT04321876: completion date: 2026-06-30 → 2026-09-30.

East West Ave Acquisition Corp. - Rights (EWAVR) was added to the exchange traded list on NASDAQ

East West Ave Acquisition Corp. - Common Stock (EWAV) was added to the exchange traded list on NASDAQ

Beyond Oil Reports Second Quarter 2026 Financial Results and Provides Business Update